VERONA PHARMA PLC's ticker is VRNA and the CUSIP is 925050106. A total of 100 filers reported holding VERONA PHARMA PLC in Q3 2023. The put-call ratio across all filers is 3.08 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $65,317,311 | -30.2% | 4,007,197 | -18.2% | 2.18% | -19.6% |
| Q2 2023 | $93,630,032 | +70.6% | 4,897,116 | +79.1% | 2.71% | +67.2% |
| Q1 2023 | $54,894,503 | -57.0% | 2,733,790 | -44.0% | 1.62% | -54.7% |
| Q4 2022 | $127,533,187 | +147.2% | 4,880,719 | -3.3% | 3.58% | +139.2% |
| Q3 2022 | $51,583,000 | +322.3% | 5,047,264 | +73.1% | 1.50% | +290.9% |
| Q2 2022 | $12,214,000 | -19.6% | 2,915,146 | -4.2% | 0.38% | +26.0% |
| Q1 2022 | $15,191,000 | -60.6% | 3,044,303 | -46.9% | 0.30% | +2.4% |
| Q4 2021 | $38,540,000 | +143.4% | 5,735,020 | +98.5% | 0.30% | +29.1% |
| Q3 2021 | $15,831,000 | -58.1% | 2,888,889 | -50.0% | 0.23% | -6.1% |
| Q2 2021 | $37,786,000 | +56.5% | 5,777,778 | +100.0% | 0.24% | -19.7% |
| Q1 2021 | $24,151,000 | +19.4% | 2,888,889 | 0.0% | 0.30% | +40.6% |
| Q4 2020 | $20,222,000 | +12.2% | 2,888,889 | 0.0% | 0.22% | -17.5% |
| Q3 2020 | $18,027,000 | +5772.0% | 2,888,889 | +12839.0% | 0.26% | +3187.5% |
| Q2 2018 | $307,000 | -72.7% | 22,327 | -60.2% | 0.01% | -74.2% |
| Q1 2018 | $1,123,000 | -52.9% | 56,168 | -71.9% | 0.03% | -60.8% |
| Q4 2017 | $2,384,000 | -61.2% | 200,000 | -50.0% | 0.08% | -32.5% |
| Q3 2017 | $6,140,000 | +163.4% | 400,000 | +100.0% | 0.12% | 0.0% |
| Q2 2017 | $2,331,000 | – | 200,000 | – | 0.12% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Abingworth LLP | 2,457,499 | $16,932,000 | 5.79% |
| Aisling Capital Management LP | 1,332,485 | $9,327,000 | 1.60% |
| Ghost Tree Capital, LLC | 810,000 | $5,670,000 | 1.26% |
| Vivo Capital, LLC | 3,048,507 | $21,340,000 | 0.95% |
| NEA Management Company, LLC | 5,108,563 | $35,760,000 | 0.94% |
| Novo Holdings A/S | 2,608,755 | $18,261,000 | 0.78% |
| Samsara BioCapital, LLC | 1,111,112 | $7,778,000 | 0.78% |
| SPHERA FUNDS MANAGEMENT LTD. | 1,033,603 | $7,235,000 | 0.64% |
| RA Capital Management | 5,100,000 | $31,824,000 | 0.44% |
| Orbimed Advisors | 5,694,841 | $39,864,000 | 0.35% |